Biological Evaluation Plan and Report Services

Our Biological Evaluation Plan and Report services support medical device manufacturers in demonstrating biological safety in line with ISO 10993 and regulatory expectations. Patient Guard helps you prepare, review, and strengthen your biological evaluation documentation for CE marking, UKCA marking, and global regulatory submissions.

Medical device biological evaluation, performance evaluation

Biological Evaluation Plan and Report Services

Medical device manufacturers must demonstrate that their devices are biologically safe for their intended use, patient contact type, and duration of contact.

A Biological Evaluation Plan (BEP) and Biological Evaluation Report (BER) are key documents used to justify biological safety and determine whether additional biocompatibility testing is required.

Patient Guard provides expert Biological Evaluation Plan and Report services for medical device manufacturers, supporting compliance with ISO 10993-1 and applicable regulatory requirements.

We help manufacturers assess material characterisation, device contact, existing evidence, toxicological risks, and biological endpoints to determine a compliant biological evaluation strategy.

Whether you are preparing a new biological evaluation, updating legacy documentation, or responding to Notified Body feedback, we provide a structured and compliant approach.

Steve Condie - Patient Guard - Regulatory Manager
"Biological safety is no longer just about 'checking boxes' with expensive lab tests; it’s about a sophisticated, risk-based assessment of how your device interacts with the human body. We focus on a 'chemistry-first' approach to ISO 10993, ensuring your device is safe, compliant, and scientifically defensible."
Steve Condie MTOPRA

Regulatory Manager

biological evaluation report ISO 10993

Why Choose Patient Guard for Biological Evaluation Support?

Established Regulatory Consultancy

Since 2017, we have supported medical device manufacturers with technical documentation and regulatory compliance for over 9 years.

Trusted by 500+ Companies

We support ambitious start-ups, scaling SMEs, and global manufacturers with comprehensive medical device compliance and market access.

ISO 10993-Focused Expertise

Our team understands biological evaluation requirements and how they fit into EU MDR, UK MDR, and global regulatory submissions.

Practical & Risk-Based Approach

We help you avoid unnecessary, expensive testing by utilising a highly structured, evidence-based biological evaluation strategy.

What Our Biological Evaluation Service Includes

Biological Evaluation Plan (BEP)

We prepare or review complete Biological Evaluation Plans that clearly define the strategy, scope, and target endpoints for your device.

Biological Evaluation Report (BER)

We draft or review Biological Evaluation Reports that thoroughly document the final safety assessments and justify your conclusions.

ISO 10993-1 Gap Assessment

We assess your existing biological safety documentation directly against ISO 10993-1 requirements to identify non-compliance.

Endpoint Assessment

We isolate relevant biological endpoints based precisely on your device type, the nature of body contact, and the total contact duration.

Characterisation Review

Our experts review available raw material, manufacturing data, and chemical characterisation profiles to safely support safety conclusions.

Testing Strategy & Justification

We clarify whether additional lab testing is needed and provide defensible scientific justification where testing is unnecessary.

Who Requires Biological Evaluation Documentation?

Biological Evaluation Requirements

Biological evaluation is required to demonstrate that a medical device is safe for its intended use and does not present unacceptable biological risks.

A compliant biological evaluation typically considers:

The biological evaluation should be risk-based, scientifically justified, and maintained throughout the device lifecycle.

Our Process

01

Step 1 – Initial consultation

We assess your device, intended use, patient contact type, and current documentation status.

02

Step 2 – Documentation review

We review existing material data, test reports, risk management files, and technical documentation.

03

Step 3 – Biological Evaluation Plan

We define the biological evaluation strategy and applicable biological endpoints.

04

Step 4 – Biological Evaluation Report

We prepare or update the report, documenting evidence, testing, gaps, and conclusions.

05

Step 5 – Final review and support

We support final checks, updates, and responses to auditor or Notified Body feedback.

biological evaluation plan ISO 10993

Medical devices we support

We support biological evaluation documentation for a wide range of medical devices, including:

Cost of Service

Premium

Biological Evaluation Plans and Reports

£ 6,000

From

Ensure regulatory compliance and market readiness with expertly prepared Biological Evaluation Plans and Reports. Pricing starts from £6,000, with preferential rates for multiple products.

Costs

  • Class I Medical Devices - £6,000
  • Class IIa Medical Devices - £8,000
  • Class IIb Medical Devices - £10,000
  • Class III Medical Devices - £12,000

Time Lines

01

Day 1–3 – Initial Assessment & Gap Analysis

Review of device materials, intended use, and existing data against ISO 10993 requirements.

02

Day 3–10 – BEP & BER Development

Preparation of Biological Evaluation Plan and Report, including endpoint assessment and justification strategy.

03

Day 10+ – Final Review & Compliance Readiness

Final documentation checks and support for Notified Body review or Technical File integration.

Frequently Asked Questions (FAQs)

A Biological Evaluation Plan defines the strategy for assessing the biological safety of a medical device, including applicable biological endpoints and required evidence.

A Biological Evaluation Report documents the results of the biological evaluation and provides the justification that the device is biologically safe for its intended use.

Biological evaluation is generally required for medical devices with direct or indirect patient contact. The depth of evaluation depends on the device type, materials, contact duration, and intended use.

Not always. Testing may not be required where sufficient existing evidence, material data, chemical characterisation, and scientific justification are available.

Yes, we can review, update, and remediate existing biological evaluation documentation to align with ISO 10993 and regulatory expectations.

Related Services

Click on the links below to discover more:

Do you need Training?

Check out Patient Guards Training Courses

Recent Blog Posts

Get in touch

Our Friendly Team are here to help.

Book a Free Consultation

Speak to one of our regulatory and compliance experts to arrange an obligation-free call. Our experienced team is ready to help you get your medical device to market.

UK Office

Speak to one of our regulatory experts

For help with the checklist or other aspects of your compliance journey, please reach out to us at Patient Guard and our experts would be happy to help.

UK Office

Get the Medical Device Technical Checklist

Thank you! The checklist is now ready to download.

checklist-tablet

Speak to one of our medical device consultants

For help with the checklist or other aspects of your compliance journey, please reach out to us at Patient Guard and our experts would be happy to help.

UK Office

Do you need support with Medical Device or IVD compliance?

We can help you!